Sampre Nutritions Stock Rises 2% Ahead of Board Meeting on Bonus and Split
By Shishta Dutta | Published at: Sep 16, 2025 05:08 PM IST

Mumbai, Sept 16, 2025 – Sampre Nutritions Ltd (BSE: 530617) shares closed with a 2% appreciation on Tuesday, rising to ₹99.52 from the last close of ₹97.57. The stock hit its day’s highest price band, reflecting sustained investor interest. Sampre Nutritions Ltd is a packaged foods company that produces confectionery and nutritional items for local and export markets.
Stock Movement
Sampre Nutritions shares closed at ₹99.52, up by 2% on September 16, 2025. Sampre Nutrition’s shares have returned 8.22% over the last 5 days, 48% over the last month, 265% over the last six months.
The stock began Tuesday’s trading at ₹99.52, which was also its intraday high and low, before closing near the opening price. This is against the last close of ₹97.57. Trading volume was 116,244 shares, equivalent to a turnover of ₹115.69 lakh. VWAP (Volume Weighted Average Price) was equal to the opening price at ₹99.52.
Currently, the market capitalisation of the company is ₹214 crore with a face value of ₹10 per share and a book value of ₹44.06. In the last year, the counter has moved between a 52-week high of ₹101.17 and a 52-week low of ₹20.90. The stock has reached an all-time high of ₹296.35 and an all-time low of ₹1.05.
Key Trigger
Investor excitement is mounting before the board meeting on September 19, 2025, when directors will decide on a stock split and bonus equity issue.
REF: https://www.bseindia.com/xml-data/corpfiling/AttachLive/4e037855-d6fb-434e-b61f-f17c76586df8.pdf
Disclaimer: At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations

